Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 227

Sort by

Sort Order Select

Journal Articles

Andean Enriched NFKB1 Haplotype Reduces Inflammation and Improves Response to Ropeginterferon Alfa-2b in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Jihyun Song, Soo Jin Kim, Josef T. Prchal

Blood (2024) 144 (Supplement 2): LBA-4.

https://doi.org/10.1182/blood-2024-213103

Published: 2024

Journal Articles

Thrombosis at High Altitude Is Not Associated with Increased Transferrin

Ricardo Amaru, Josef T. Prchal, Daniela Paton, Mireya Carrasco, Emma Mancilla, Victor R. Gordeuk

Blood (2024) 144 (Supplement 1): 5561.

https://doi.org/10.1182/blood-2024-204118

Published: 2024

Journal Articles

Selinexor-Driven Regulation of Proinflammatory Cytokines May Lead to Stabilization of Hematologic Parameters and Bone Marrow Function in Patients with Myelofibrosis: Case Study from the Phase 1 Sentry Trial

Haris Ali, Keri Maher, Ashwin Kishtagari, Sanjay R Mohan, Josef T. Prchal, Yi Chai, Christopher J. Walker, Trinayan Kashyap, Steve Kye, Srinivas K Tantravahi

Blood (2024) 144 (Supplement 1): 6676.

https://doi.org/10.1182/blood-2024-207778

Published: 2024

Journal Articles

Prospective Ropeginterferon Alfa-2b Therapy in PV & ET Influences Prothrombotic, Inflammatory and Hypoxia Inducible Factors Activities and Effect of Concomitant DNMT3A Mutation

Jihyun Song, Soo Jin Kim, Yewon Lim, Grace Min, Amanda Smith, Aaron Swomley, Tsewang Tashi, Josef T. Prchal

Blood (2024) 144 (Supplement 1): 6570.

https://doi.org/10.1182/blood-2024-211716

Published: 2024

Journal Articles

Quality of Life Evaluation for Patients on Ropeginterferon Alpha-2b Versus Other Best Available Therapies

Brynn Parsegov, Halee Namanny, Maren Campbell, Yue Zhang, Feiyun Yan, Michael Christiansen, Amanda Smith, Tsewang Tashi, Josef T. Prchal

Blood (2024) 144 (Supplement 1): 1791.

https://doi.org/10.1182/blood-2024-204440

Published: 2024

Journal Articles

Iron Deficiency Correction in Myeloproliferative Neoplasms Reduces Thrombosis Risk Via Decreased P-Selectin

Jihyun Song, Soo Jin Kim, Grace Min, Yewon Lim, Josef T. Prchal

Blood (2024) 144 (Supplement 1): 1758.

https://doi.org/10.1182/blood-2024-211848

Published: 2024

Journal Articles

Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Patients with Myelofibrosis: Long Term Follow up from XPORT-MF-034 Suggestive of Disease Modification

Srinivas K. Tantravahi, Ashwin Kishtagari, Keri Maher, Sanjay Mohan, Josef T. Prchal, Xulong Wang, Kamal Chamoun, Christopher J Walker, Pietro Taverna, Haris Ali

Blood (2023) 142 (Supplement 1): 622.

https://doi.org/10.1182/blood-2023-180844

Published: 2023

Journal Articles

Ropeginterferon Alfa-2b Blunts Hyperactive JAK2 Activity in Polycythemia Vera and Essential Thrombocythemia

Jihyun Song, Josef T. Prchal

Blood (2023) 142 (Supplement 1): 3162.

https://doi.org/10.1182/blood-2023-190172

Published: 2023

Journal Articles

Real-World Experience of Ropeginterferon-Alfa Treatment of PV and ET - Two Centers Experience

Tsewang Tashi, Brandi N. Reeves, Soo Jin Kim, Hyewon Jeong, Sheh-Li Chen, Brynn Parsegov, Josef T. Prchal

Blood (2023) 142 (Supplement 1): 6397.

https://doi.org/10.1182/blood-2023-191268

Published: 2023

Journal Articles

An Atypical Somatic Calr Variant Acquired in Cis to a Germline Calr variant Induces Constitutive Signaling of the Thrombopoietin Receptor and Results in Essential Thrombocythemia

Laetitia Borderon, Jihyun Song, Soo Jin Kim, Christophe Marzac, Christine Bellanné-Chantelot, Nicolas Papadopoulos, Stefan N. Constantinescu, William Vainchenker, Isabelle Plo, Josef T. Prchal, Caroline Marty

Blood (2023) 142 (Supplement 1): 3161.

https://doi.org/10.1182/blood-2023-179381

Published: 2023

Journal Articles

Exploratory Study on Impact of Comorbid Sleep Apnea Treatment in Patients with Polycythemia Vera and Essential Thrombocythemia

Krishna Sundar, Jihyun Song, Soo Jin Kim, Binal Shah, Kimberly Workman, Braxton Smith, Ellen Brooks, Gabrielle Matinkhah, Srinivas K. Tantravahi, Tsewang Tashi, Victor R. Gordeuk, Josef T. Prchal, Brynn Parsegov

Blood (2023) 142 (Supplement 1): 6414.

https://doi.org/10.1182/blood-2023-182884

Published: 2023

Journal Articles

Alternatively Spliced ATP6V1H induces Inflammation in Polycythemia Vera and Essential Thrombocythemia

Jihyun Song, Seonggyun Han, Soo Jin Kim, Josef T. Prchal

Blood (2023) 142 (Supplement 1): 6338.

https://doi.org/10.1182/blood-2023-188380

Published: 2023

Journal Articles

EnvIRONment modifies polycythemia vera

Josef T. Prchal, Brandi N. Reeves

Blood (2023) 141 (17): 2042–2044.

https://doi.org/10.1182/blood.2023020065

Published: 2023

Journal Articles

Andean Aymara Enriched Genetic Variants Are Beneficial to High Altitude Adaptation of Andean Quechuas Living at 5000 m

Ricardo Amaru, Emerson Cayo, Julieta Luna, Teddy Quispe, Josef T. Prchal, Jihyun Song

Blood (2022) 140 (Supplement 1): 11035–11036.

https://doi.org/10.1182/blood-2022-170866

Published: 2022

Journal Articles

A Novel Autosomal Dominant JAK2 R715T Mutation Causes Polycythemia Vera in 3 Generations

Soo Jin Kim, Jihyun Song, Nicolas Papadopoulos, Jessica Meznarich, Grace Min, Stefan N. Constantinescu, Josef T. Prchal

Blood (2022) 140 (Supplement 1): 6742–6743.

https://doi.org/10.1182/blood-2022-170075

Published: 2022

Journal Articles

Congenital Erythrocytosis Due to Novel CMTR1 K769L Mutation Has Augmented Hypoxia Signaling and Features of Both Primary and Secondary Erythrocytosis

Jihyun Song, Lorenzo D. Botto, Beverly Schaefer, Soo Jin Kim, Tatiana Tvrdik, Rong Mao, Undiagnosed Diseases Network (UDN), Josef T. Prchal

Blood (2022) 140 (Supplement 1): 1243–1244.

https://doi.org/10.1182/blood-2022-167863

Published: 2022

Journal Articles

Do Andean Aymaras' Evolutionary Selected Genes to High Altitude Hypoxia Also Influence Hemoglobin Concentration of Europeans and Their Acute Hypoxia Responses?

Divya Sundar, Grace Min, Martin Burtscher, Ricardo Amaru, Maria Wille, Soo Jin Kim, Josef T. Prchal, Jihyun Song

Blood (2022) 140 (Supplement 1): 5333–5334.

https://doi.org/10.1182/blood-2022-170580

Published: 2022

Journal Articles

A Phase 1, Open-Label, Dose-Escalation Study of Selinexor Plus Ruxolitinib in Patients with Treatment-Naïve Myelofibrosis

Haris Ali, Ashwin Kishtagari, Keri Maher, Sanjay R Mohan, Karen Ansaldo, Xulong Wang, Kamal Chamoun, Josef T. Prchal, Srinivas K. Tantravahi

Blood (2022) 140 (Supplement 1): 3986–3987.

https://doi.org/10.1182/blood-2022-160039

Published: 2022

Journal Articles

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood (2022) 139 (19): 2931–2941.

https://doi.org/10.1182/blood.2021012743

Published: 2022

Includes: Supplemental data

Journal Articles

Iron Deficiency in Polycythemia Vera Increases HIF Activity and Transcription of Prothrombotic Genes

Jihyun Song, Soo Jin Kim, Perumal Thiagarajan, Josef T. Prchal

Blood (2021) 138 (Supplement 1): 2549.

https://doi.org/10.1182/blood-2021-153221

Published: 2021

NARROW

Andean Enriched NFKB1 Haplotype Reduces Inflammation and Improves Response to Ropeginterferon Alfa-2b in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Thrombosis at High Altitude Is Not Associated with Increased Transferrin

Selinexor-Driven Regulation of Proinflammatory Cytokines May Lead to Stabilization of Hematologic Parameters and Bone Marrow Function in Patients with Myelofibrosis: Case Study from the Phase 1 Sentry Trial

Prospective Ropeginterferon Alfa-2b Therapy in PV & ET Influences Prothrombotic, Inflammatory and Hypoxia Inducible Factors Activities and Effect of Concomitant DNMT3A Mutation

Quality of Life Evaluation for Patients on Ropeginterferon Alpha-2b Versus Other Best Available Therapies

Iron Deficiency Correction in Myeloproliferative Neoplasms Reduces Thrombosis Risk Via Decreased P-Selectin

Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Patients with Myelofibrosis: Long Term Follow up from XPORT-MF-034 Suggestive of Disease Modification

Ropeginterferon Alfa-2b Blunts Hyperactive JAK2 Activity in Polycythemia Vera and Essential Thrombocythemia

Real-World Experience of Ropeginterferon-Alfa Treatment of PV and ET - Two Centers Experience

An Atypical Somatic Calr Variant Acquired in Cis to a Germline Calr variant Induces Constitutive Signaling of the Thrombopoietin Receptor and Results in Essential Thrombocythemia

Exploratory Study on Impact of Comorbid Sleep Apnea Treatment in Patients with Polycythemia Vera and Essential Thrombocythemia

Alternatively Spliced ATP6V1H induces Inflammation in Polycythemia Vera and Essential Thrombocythemia

EnvIRONment modifies polycythemia vera

Andean Aymara Enriched Genetic Variants Are Beneficial to High Altitude Adaptation of Andean Quechuas Living at 5000 m

A Novel Autosomal Dominant JAK2 R715T Mutation Causes Polycythemia Vera in 3 Generations

Congenital Erythrocytosis Due to Novel CMTR1 K769L Mutation Has Augmented Hypoxia Signaling and Features of Both Primary and Secondary Erythrocytosis

Do Andean Aymaras' Evolutionary Selected Genes to High Altitude Hypoxia Also Influence Hemoglobin Concentration of Europeans and Their Acute Hypoxia Responses?

A Phase 1, Open-Label, Dose-Escalation Study of Selinexor Plus Ruxolitinib in Patients with Treatment-Naïve Myelofibrosis

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Iron Deficiency in Polycythemia Vera Increases HIF Activity and Transcription of Prothrombotic Genes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only